[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inhibikase Therapeutics Inc (IKT)

Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inhibikase Therapeutics Inc 1000 N. WEST STREET SUITE 1200 WILMINGTON DE 19801 USA

www.inhibikase.com Employees: 35 P: 302-295-3800

Sector:

Medical

Description:

Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing therapeutics for Parkinson's disease and related disorders. The company operates principally in Boston, Massachusetts. Inhibikase Therapeutics Inc. is headquartered in Atlanta, Georgia.

Key Statistics

Overview:

Market Capitalization, $K 220,495
Enterprise Value, $K 81,275
Shares Outstanding, K 132,033
Float, K 122,395
% Float 92.70%
Short Interest, K 17,691
Short Float 13.40%
Days to Cover 26.52
Short Volume Ratio 0.72
% of Insider Shareholders 7.30%
% of Institutional Shareholders 3.81%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -48,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,380 K
EBIT, $ -55,220 K
EBITDA, $ -55,160 K

Growth:

1-Year Return -12.57%
3-Year Return -54.45%
5-Year Return -90.40%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 76.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 05/12/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year 33.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 06/30/23

IKT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.31%
Return-on-Assets % -38.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.32
Book Value/Share 1.27
Interest Coverage -1.18
60-Month Beta 0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.